ZA963915B - Obesity gene product. - Google Patents

Obesity gene product.

Info

Publication number
ZA963915B
ZA963915B ZA9603915A ZA963915A ZA963915B ZA 963915 B ZA963915 B ZA 963915B ZA 9603915 A ZA9603915 A ZA 9603915A ZA 963915 A ZA963915 A ZA 963915A ZA 963915 B ZA963915 B ZA 963915B
Authority
ZA
South Africa
Prior art keywords
gene product
obesity gene
obesity
product
gene
Prior art date
Application number
ZA9603915A
Other languages
English (en)
Inventor
Hansen Maxwell Hsiung
Dennis Paul Smith
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA963915B publication Critical patent/ZA963915B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/5759Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9603915A 1995-05-19 1996-05-16 Obesity gene product. ZA963915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44530595A 1995-05-19 1995-05-19

Publications (1)

Publication Number Publication Date
ZA963915B true ZA963915B (en) 1997-11-17

Family

ID=23768399

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9603915A ZA963915B (en) 1995-05-19 1996-05-16 Obesity gene product.

Country Status (10)

Country Link
EP (1) EP0743321A3 (xx)
JP (1) JPH11505706A (xx)
AR (1) AR002742A1 (xx)
AU (1) AU5795496A (xx)
CA (1) CA2221303A1 (xx)
IL (1) IL118297A0 (xx)
PE (1) PE50997A1 (xx)
WO (1) WO1996036644A1 (xx)
YU (1) YU29596A (xx)
ZA (1) ZA963915B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6001968A (en) * 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6124448A (en) * 1994-08-17 2000-09-26 The Rockfeller University Nucleic acid primers and probes for the mammalian OB gene
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US6225446B1 (en) 1995-12-06 2001-05-01 Schering Corporation Mutational variants of mammalian proteins
WO1997020933A2 (en) * 1995-12-06 1997-06-12 Schering Corporation MUTATIONAL VARIANTS OF MAMMALIAN Ob GENE PROTEINS
AU1750997A (en) * 1996-01-19 1997-08-11 Eli Lilly And Company Obesity protein formulations
WO1997026916A1 (en) * 1996-01-25 1997-07-31 Eli Lilly And Company Obesity protein analog compounds and formulations thereof
US6001816A (en) * 1996-06-20 1999-12-14 Merck & Co., Inc. Gene therapy for leptin deficiency
US6297027B1 (en) * 1996-07-31 2001-10-02 Purina Mills, Inc. Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
US6277592B1 (en) * 1996-07-31 2001-08-21 Purina Mills, Inc. Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof
US20020110857A1 (en) * 1996-07-31 2002-08-15 Spurlock Michael E. Bovine leptin protein, antisense and antibody
US5965521A (en) * 1997-02-25 1999-10-12 Eli Lilly Company Pulsatile delivery of leptin receptor ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
CA2211664A1 (en) * 1995-01-31 1996-08-08 Eli Lilly And Company Anti-obesity proteins

Also Published As

Publication number Publication date
EP0743321A3 (en) 1997-01-15
JPH11505706A (ja) 1999-05-25
WO1996036644A1 (en) 1996-11-21
YU29596A (sh) 1998-07-10
PE50997A1 (es) 1997-12-18
AU5795496A (en) 1996-11-29
EP0743321A2 (en) 1996-11-20
IL118297A0 (en) 1996-09-12
AR002742A1 (es) 1998-04-29
CA2221303A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
PL316548A1 (en) Alimentary product set
ZA967315B (en) Biphenylamides.
EP0679716A4 (en) GENE SIGNATURE.
MX213417B (es) Fenilpiridazinonas.
ZA941281B (en) Hyper-sensitivity related gene.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
ZA963915B (en) Obesity gene product.
HUP9901175A3 (en) Product made from pasta
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA98295B (en) Food product.
ZA961082B (en) DNA sequence.
ZA961869B (en) Food product.
GB9609730D0 (en) An improved product
EP0736599A3 (en) The rat obesity gene, its gene product and its production
ZA966244B (en) Feed conveyor.
ZA961828B (en) Food product finisher.
GB9505524D0 (en) Product
AU4862396A (en) Human obesity gene
ZA966399B (en) Endothelin-receptor-antagonists.
ZA967545B (en) Pharmaceuticals.
ZA966750B (en) Halogenobenzimidazoles.
ZA966933B (en) Endothelin-receptor-antagonists.
GB9506051D0 (en) Gene expression
ZA98413B (en) Food product.